| P2093 | author name string | Di Zhang | |
| | Hyun S Kim | |
| | Minzhi Xing | |
| | Johannes M Ludwig | |
| P2860 | cites work | Society of Interventional Radiology Clinical Practice Guidelines | Q79091576 |
| | Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC) | Q83157920 |
| | Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol | Q83371638 |
| | [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma] | Q83373369 |
| | Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma | Q84603257 |
| | Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma | Q84782537 |
| | Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization | Q85015670 |
| | Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma | Q85064441 |
| | Random-effects meta-analysis of inconsistent effects. In response | Q85230526 |
| | Estimating the mean and variance from the median, range, and the size of a sample | Q24801782 |
| | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| | Meta-analysis in clinical trials | Q27860779 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization | Q28111719 |
| | Indirect comparisons of competing interventions | Q28183606 |
| | Hepatocellular carcinoma | Q29616359 |
| | The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 |
| | Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial | Q33414645 |
| | Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | Q33691454 |
| | Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization | Q33797067 |
| | Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. | Q33918062 |
| | Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma | Q34089023 |
| | Radioembolization of yttrium-90 microspheres for hepatic malignancy | Q34563515 |
| | Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis | Q34874473 |
| | Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature. | Q34991643 |
| | Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes | Q35004090 |
| | Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 |
| | Research reporting standards for radioembolization of hepatic malignancies. | Q35111887 |
| | Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma. | Q35164855 |
| | Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial | Q36383875 |
| | Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE) | Q36516386 |
| | Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 |
| | 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness | Q38162894 |
| | The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. | Q38217657 |
| | Transarterial chemoembolization and radioembolization. | Q38264958 |
| | Current surgical treatment strategies for hepatocellular carcinoma in North America | Q38266862 |
| | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 |
| | Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses | Q39735046 |
| | Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma | Q48058236 |
| | Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. | Q51082254 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2031-2041 | |
| P577 | publication date | 2016-08-25 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma. | |
| P478 | volume | 27 | |